Beijing Wansheng Pharmaceutical Co. Ltd
Located in the Industrial Development Zone in Tongzhou, Beijing, and as a high-tech company in Beijing high-tech and Zhongguanchun High-Tech districts, the Company’s core business is in developing new drugs, medicine …[Unfolded]Located in the Industrial Development Zone in Tongzhou, Beijing, and as a high-tech company in Beijing high-tech and Zhongguanchun High-Tech districts, the Company’s core business is in developing new drugs, medicine intermediaries, and drug manufacturing and marketing, and is among the first group of fast-developing companies (G20) in bio-medicine development and manufacturing.
The company has medicine intermediaries, granules, tablets and capsules that meet the GMP (Good Manufacturing Practice) standards, and its research facilities meet the GLP (Good Laboratory Practice) standards in new drug development and production. Now the company has 47 different kinds of medicine intermediaries and formulas that have won the approval from the State Medicine Board.
The Company has won many honors and awards, including “Beijing Medicine Assurance Award”, “Beijing Company of Trust and Honesty”, etc. Its products, Compound α-Ketoacid Tablets, Olmesartan Medoxomil Tablets, and smog filtering nose masks are awarded Beijing’s New Technology Products, and the Urinary Dynamic Monitoring Instrument won patents both in China and Japan. The “Wansheng-Beijing Chemical Engineering University Nano Medicine Joint Laboratory” is designated as the Nano Medicine Engineering Technology Research Center of Beijing.
Wansheng Medicine Cangzhou Intermediary subsidiary plant started construction in 2005, occupying an area of more than 133,333 square meters with ¥0.284 billion RMB investment. Once it’s completed, it will have the capacity of producing 200tons of medicine intermediaries and will become another profit generating division. [Return]
The company has medicine intermediaries, granules, tablets and capsules that meet the GMP (Good Manufacturing Practice) standards, and its research facilities meet the GLP (Good Laboratory Practice) standards in new drug development and production. Now the company has 47 different kinds of medicine intermediaries and formulas that have won the approval from the State Medicine Board.
The Company has won many honors and awards, including “Beijing Medicine Assurance Award”, “Beijing Company of Trust and Honesty”, etc. Its products, Compound α-Ketoacid Tablets, Olmesartan Medoxomil Tablets, and smog filtering nose masks are awarded Beijing’s New Technology Products, and the Urinary Dynamic Monitoring Instrument won patents both in China and Japan. The “Wansheng-Beijing Chemical Engineering University Nano Medicine Joint Laboratory” is designated as the Nano Medicine Engineering Technology Research Center of Beijing.
Wansheng Medicine Cangzhou Intermediary subsidiary plant started construction in 2005, occupying an area of more than 133,333 square meters with ¥0.284 billion RMB investment. Once it’s completed, it will have the capacity of producing 200tons of medicine intermediaries and will become another profit generating division. [Return]